|
143 Pharmacy
advice in the Which? spotlight again Advice given in community
pharmacies is unsatisfactory in four out of 10 cases, the Consumers'
Association says, having sent its undercover researchers into pharmacies
for the fourth time in 10 years ...more
143 Pharmacists
need more support and better incentives to improve public health advice Following
the report by Which? magazine (see above) criticising the advice given
in some community pharmacies, there have been calls for more financial
support, training and standards, and incentives to help pharmacists provide
better public health information ...more
144 Another
HRT trial stopped as women with previous breast cancer found to be at
high risk of recurrence Another hormone replacement therapy trial has been terminated because initial results show that women with a history of breast cancer allocated to receive HRT for menopausal symptoms were at “unacceptably high” risk of breast cancer compared with women allocated to best treatment without hormones
...more
144 Higher
doses of aspirin needed to reduce risk of colorectal adenoma Taking
aspirin over the short- or long-term can reduce the risk for colorectal
adenoma by 25 per cent, say researchers, but the greatest protective
effect is seen at substantially higher doses than those currently recommended
for the prevention of cardiovascular disease ...more
144 Weekly
paclitaxel improves response in metastatic breast cancer Treatment with paclitaxel (Taxol) based on a weekly or two-weekly dosage regimen —rather than a three-weekly regimen — improves response and reduces toxicity, according to early studies in operable breast cancer reported at a conference last month
...more
145 At
least 523 tonnes of medicines wasted each year Just over 523 tonnes of unwanted medicines were returned to community pharmacies in England and Wales during 2002–03, according to new Government figures
...more
145 Generic
NHS model for chronic care needed The NHS should have an underlying
generic model for the care of patients with chronic diseases, health
policy experts say ...more
145 Fears
that Scotland faces prescription pricing disruption Fears
that prescription pricing in Scotland could be disrupted again have been
highlighted this week by the Scottish Pharmaceutical General Council
...more
145 Relaunch
for DoH website The Department of Health website is being
relaunched on 9 February with a new, thematic structure and more information
about the Department's publications ...more
145 Supplementary
prescribing All 17 pharmacists who were considered at last
week's assessment board for supplementary prescribing at Robert Gordon
University passed ...more
145 APS/Berk
sales team APS/Berk is doubling its number of territory managers
and focusing them entirely on independent pharmacies and dispensing doctors
over the next few months ...more |
146 Clear steps
for prescription checking at Rowlands Pharmacy Dispensing
into clear plastic bags is helping pharmacists check prescriptions when
they are handed over to customers in refurbished branches of Rowlands
Pharmacy ...more
146 Patients
should be able to buy Tamiflu, according to NPA Patients should
be able to buy Tamiflu (oseltamivir) privately in pharmacies under a
patient group direction rather than having to get a private prescription
for it, the National Pharmaceutical Association has told the Department
of Health ...more
146 Big debate
on public health wanted by Government Health Secretary John
Reid has called for a big debate on the roles of the Government, individuals
and industries in improving public health ...more
146 Pharmacists'
personal habits under scrutiny Pharmacists, and other health
professionals, have been committed to leading by example in the fight
against smoking ...more
147 Atypicals
have different risk profiles for diabetes Patients treated
with atypical antipsychotic agents should be monitored carefully given
the increased risk of weight gain and diabetes associated with this group
of drugs, according to the American Diabetes Association and other US
medical groups ...more
147 Triple therapy
based on protease inhibitor best for previously treated HIV patients Patients
with HIV treated previously with nucleoside reverse transcriptase inhibitors
(NRTIs) fare better on a triple antiretroviral regimen based on a protease
inhibitor than on some other regimens, a study has shown ...more
147 Novel anti-emetic
therapy launched by MSD A new anti-emetic therapy has recently
been launched by Merck Sharp & Dohme. Emend (aprepitant) will be
used in combination with other therapies for the prevention of nausea
and vomiting associated with cisplatin-based cancer chemotherapy ...more
148 NPA training
modules launched Two National Pharmaceutical Association training
modules, one on pharmacy law and ethics and the other on the Drug Tariff,
are now available on CD-ROM ...more
148 New European
vitamin law challenged in the High Court A ruling is to be
sought from the European Court of Justice on whether the European Commission
has exceeded its powers by introducing new restrictions on the sale of
vitamin and mineral food supplements ...more
148 British clinical
pharmacy teachers head for Indonesia Four hospital pharmacists
have flown to Indonesia this week to take part in a clinical pharmacy
teaching course ...more
148 Europe wants
more cross-border services The European Commission wants to
remove obstacles that prevent the provision of a wide range of services,
including health care services, throughout Europe, no matter where in
the union those services are based ...more
148 Ban proposed
for herbals containing senecio The MHRA is consulting on a
proposed ban on the sale of unlicensed herbal medicines for internal
use that contain plants of the genus Senecio (ragworts) or their
extracts ...more |
The
Pharmaceutical Journal